Mean platelet volume predicts outcome in patients with asymptomatic carotid artery disease

Florian J Mayer1, Matthias Hoke, Martin Schillinger

  • 1Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.

Insights

Mean platelet volume (MPV) is a significant predictor of adverse cardiovascular events in patients with asymptomatic carotid artery disease. Higher MPV levels indicate an increased risk of major adverse cardiovascular events (MACE).

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Atherosclerosis Research

Background:

  • Platelets are implicated in atherothrombosis and atherosclerosis pathogenesis.
  • Mean platelet volume (MPV) is a potential biomarker for cardiovascular risk.

Purpose of the Study:

  • To investigate if MPV predicts clinical outcomes and atherosclerosis progression.
  • To assess the association between MPV and major adverse cardiovascular events (MACE) in patients with asymptomatic carotid artery disease.

Main Methods:

  • Prospective study of 1006 patients with asymptomatic carotid atherosclerosis.
  • Clinical follow-up for MACE (myocardial infarction, revascularization, stroke, death).
  • Duplex sonography used for carotid stenosis evaluation.

Main Results:

  • Increased MPV levels significantly correlated with a higher risk of MACE (adjusted HR 1.22 per SD increase).
  • Patients in the highest MPV quintile (>11.8 fL) had a significantly higher MACE rate (41.3% vs. 29.3%) and adjusted HR of 1.65.
  • No significant association found between MPV and carotid stenosis degree or progression.

Conclusions:

  • Mean platelet volume is an independent predictor of adverse cardiovascular outcomes.
  • MPV may serve as a valuable prognostic marker in patients with asymptomatic carotid atherosclerosis.
Abstract